Natixis Merck & Co., Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Merck & Co., Inc. stock. As of the latest transaction made, Natixis holds 316,780 shares of MRK stock, worth $31.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

316,780

Previous 395,525 19.91%

Holding current value

$31.2 Million

Previous $49 Million 26.53%

% of portfolio

0.2%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $8.75 Million - $10.2 Million	-78,745 Reduced 19.91%	316,780 $36 Million
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $112 Million - $120 Million	-904,577 Reduced 69.58%	395,525 $49 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $70 Million - $81.5 Million	-617,897 Reduced 32.22%	1,300,102 $172 Million
Q4 2023 Feb 13, 2024	BUY	$100.18 - $109.02 $104 Million - $113 Million	1,034,806 Added 117.17%	1,917,999 $209 Million
Q3 2023 Nov 14, 2023	BUY	$102.95 - $114.33 $40.4 Million - $44.9 Million	392,860 Added 80.12%	883,193 $90.9 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $20.5 Million - $22.3 Million	-188,794 Reduced 27.8%	490,333 $56.6 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $30 Million - $33.4 Million	-291,077 Reduced 30.0%	679,127 $72.3 Million
Q4 2022 Feb 24, 2023	BUY	$87.44 - $112.11 $4.9 Million - $6.28 Million	56,005 Added 6.13%	970,204 $108 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $199 Million - $255 Million	-2,272,453 Reduced 71.31%	914,199 $101 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $238 Million - $267 Million	2,815,455 Added 758.48%	3,186,652 $275 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $152 Million - $173 Million	-1,824,790 Reduced 83.1%	371,197 $33.9 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $115 Million - $129 Million	1,564,187 Added 247.58%	2,195,987 $180 Million
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $94.7 Million - $119 Million	-1,309,825 Reduced 67.46%	631,800 $48.4 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $19.3 Million - $21.2 Million	-268,753 Reduced 12.16%	1,941,625 $146 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $41.5 Million - $45.9 Million	589,914 Added 36.4%	2,210,378 $172 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $50.8 Million - $59.8 Million	-737,857 Reduced 31.29%	1,620,464 $125 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $111 Million - $123 Million	1,547,137 Added 190.73%	2,358,321 $193 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $51.6 Million - $58.5 Million	705,015 Added 664.05%	811,184 $67.3 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $161 Million - $183 Million	-2,281,207 Reduced 95.55%	106,169 $8.21 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $115 Million - $159 Million	1,814,627 Added 316.83%	2,387,376 $181 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $43.3 Million - $48.9 Million	-558,099 Reduced 49.35%	572,749 $52.1 Million
Q3 2019 Nov 13, 2019	SELL	$76.08 - $82.93 $57.6 Million - $62.8 Million	-756,753 Reduced 40.09%	1,130,848 $95.2 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $132 Million - $154 Million	1,887,601 New	1,887,601 $158 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $153 Million - $177 Million	-2,340,208 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $55.1 Million - $64.7 Million	954,271 Added 68.85%	2,340,208 $166 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $84.1 Million - $98.8 Million	-1,654,921 Reduced 54.42%	1,385,937 $84.1 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $117 Million - $136 Million	2,287,728 Added 303.76%	3,040,858 $166 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $1.21 Million - $1.44 Million	23,370 Added 3.2%	753,130 $42.4 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $42.8 Million - $46.1 Million	729,760	729,760 $46.7 Million

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account